Home Page
9.29.2004
 Of Gooses and Ganders 
Anyone who appreciates irony will revel in the news that the Supreme Court has granted cert in the eminent domain case of Kelo v. New London. The issue is whether a state is constitutionally allowed to exercise its power to take property "for public use" when its purpose is to transfer the property to a private corporation which promises to generate more tax revenue for the government than comes from the existing use.

The irony? The beneficiary corporation involved is Pfizer, the big pharmaceutical house, which is thus putting itself squarely on the side of government's plenary power to do anything it damn well pleases with anyone's property.

Of course, in other contexts that are far more important to them, the pharma companies are desperately defending their property rights (in the form of patents) against whimsical governments that would destroy the research goose that lays the long-term golden egg of innovation by appropriating the fruits of that research for the sake of short-term demagoguery.

So Pfizer ought to be on Kelo's side, not New London's. Perhaps the public policy office should start talking to the real estate department.

posted by James DeLong : 9/29/2004 09:26:41 AM

This page is powered by Blogger. Isn't yours?

 

IPcentral WebLog
Blog Main
Recent Posts
  More Induction
Pharma Innovation
WSJ Articles on Music Downloading
The Future History of P2P
Moore's Law Marches On
More Riffs on Posner
Tech Environmental Quality Index (TEQI)
Posner, Eldred, and Fair Use
The Mysterious Origins of the Induce Act
Morality and Medicine
Archives by Month
  December 2003
January 2004
February 2004
March 2004
April 2004
May 2004
June 2004
July 2004
August 2004
September 2004
October 2004
November 2004
December 2004
Links
  PFF Blog
Atom.xml Site Feed
   
 
Home Page IPcentral Weblog - Intellectual Property and Copyright Commentary
Home Page
9.29.2004
 Of Gooses and Ganders 
Anyone who appreciates irony will revel in the news that the Supreme Court has granted cert in the eminent domain case of Kelo v. New London. The issue is whether a state is constitutionally allowed to exercise its power to take property "for public use" when its purpose is to transfer the property to a private corporation which promises to generate more tax revenue for the government than comes from the existing use.

The irony? The beneficiary corporation involved is Pfizer, the big pharmaceutical house, which is thus putting itself squarely on the side of government's plenary power to do anything it damn well pleases with anyone's property.

Of course, in other contexts that are far more important to them, the pharma companies are desperately defending their property rights (in the form of patents) against whimsical governments that would destroy the research goose that lays the long-term golden egg of innovation by appropriating the fruits of that research for the sake of short-term demagoguery.

So Pfizer ought to be on Kelo's side, not New London's. Perhaps the public policy office should start talking to the real estate department.

posted by James DeLong : 9/29/2004 09:26:41 AM

This page is powered by Blogger. Isn't yours?

 

IPcentral WebLog
Blog Main
Recent Posts
  More Induction
Pharma Innovation
WSJ Articles on Music Downloading
The Future History of P2P
Moore's Law Marches On
More Riffs on Posner
Tech Environmental Quality Index (TEQI)
Posner, Eldred, and Fair Use
The Mysterious Origins of the Induce Act
Morality and Medicine
Archives by Month
  December 2003
January 2004
February 2004
March 2004
April 2004
May 2004
June 2004
July 2004
August 2004
September 2004
October 2004
November 2004
December 2004
Links
  PFF Blog
Atom.xml Site Feed
   
 
Home Page